AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL.
Sondhi D, Peterson DA, Giannaris EL, Sanders CT, Mendez BS, De B, Rostkowski AB, Blanchard B, Bjugstad K, Sladek JR Jr, Redmond DE Jr, Leopold PL, Kaminsky SM, Hackett NR, Crystal RG.
Sondhi D, et al. Among authors: crystal rg.
Gene Ther. 2005 Nov;12(22):1618-32. doi: 10.1038/sj.gt.3302549.
Gene Ther. 2005.
PMID: 16052206